These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23127263)

  • 21. Lamotrigine in resistant childhood epilepsy.
    Battino D; Buti D; Croci D; Estienne M; Fazio A; Granata T; Pisani F; Rota M; Avanzini G
    Neuropediatrics; 1993 Dec; 24(6):332-6. PubMed ID: 8133979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs.
    Chen C; Casale EJ; Duncan B; Culverhouse EH; Gilman J
    Pharmacotherapy; 1999 Apr; 19(4):437-41. PubMed ID: 10212015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamotrigine therapeutic thresholds.
    Søndergaard Khinchi M; Nielsen KA; Dahl M; Wolf P
    Seizure; 2008 Jul; 17(5):391-5. PubMed ID: 18180178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study.
    Knoester PD; Keyser A; Renier WO; Egberts AC; Hekster YA; Deckers CL
    Epilepsy Res; 2005 Jun; 65(1-2):93-100. PubMed ID: 16023833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
    Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
    Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antiepileptic drug comedication on lamotrigine clearance.
    Weintraub D; Buchsbaum R; Resor SR; Hirsch LJ
    Arch Neurol; 2005 Sep; 62(9):1432-6. PubMed ID: 16157751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamotrigine monotherapy in children.
    Barron TF; Hunt SL; Hoban TF; Price ML
    Pediatr Neurol; 2000 Aug; 23(2):160-3. PubMed ID: 11020642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of childhood epilepsy with lamotrigine. An evaluation of efficacy in different types of epilepsy].
    Uldall PV; Sommer B
    Ugeskr Laeger; 1996 Apr; 158(14):1973-6. PubMed ID: 8650772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
    Thome-Souza S; Valente KD
    Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of uridine diphosphate glucuronosyltransferase inducers and inhibitors on the plasma lamotrigine concentration in pediatric patients with refractory epilepsy.
    Yamamoto Y; Takahashi Y; Imai K; Ikeda H; Takahashi M; Nakai M; Inoue Y; Kagawa Y
    Drug Metab Pharmacokinet; 2015 Jun; 30(3):214-20. PubMed ID: 25825021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of an effect of topiramate on lamotrigine serum concentrations.
    Berry DJ; Besag FM; Pool F; Natarajan J; Doose D
    Epilepsia; 2002 Aug; 43(8):818-23. PubMed ID: 12180999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy.
    Sander JW; Trevisol-Bittencourt PC; Hart YM; Patsalos PN; Shorvon SD
    Epilepsy Res; 1990 Dec; 7(3):226-9. PubMed ID: 2289481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.